Medivir AB (publ) (LON:0GP7)
2.060
0.00 (0.00%)
At close: Feb 18, 2025
Medivir AB Revenue
In the year 2024, Medivir AB had annual revenue of 3.50M SEK, down -54.15%. Medivir AB had revenue of 1.00M in the quarter ending December 31, 2024, a decrease of -77.44%.
Revenue
3.50M SEK
Revenue Growth
-54.15%
P/S Ratio
n/a
Revenue / Employee
350.00K SEK
Employees
10
Market Cap
17.17M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.50M | -4.13M | -54.15% |
Dec 31, 2023 | 7.63M | 3.23M | 73.16% |
Dec 31, 2022 | 4.41M | -27.99M | -86.39% |
Dec 31, 2021 | 32.39M | 11.96M | 58.56% |
Dec 31, 2020 | 20.43M | 11.71M | 134.18% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Genus | 668.80M |